Advertisement

Topics

Skyharbour Update on Summer Drill and Field Programs, Assessment Credit Relief Granted for All Projects in the Athabasca Basin

20:00 EDT 26 Jul 2015 | Globe Newswire

VANCOUVER, British Columbia, July 27, 2015 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V:SYH) (OTC Grey:SYHBF) (Frankfurt:SC1N) (the "Company") is pleased to provide an update on its fully-funded, summer exploration programs and announces that the government of Saskatchewan has granted regulatory relief to the Company with respect to all four of its drill-ready uranium projects in Northern Saskatchewan.

Skyharbour's Uranium Project Portfolio in the Athabasca Basin:

http://skyharbourltd.com/_resources/SYH_Landpackage_2014.jpg

Summer 2015 Exploration Programs at Preston and Falcon Point Uranium Projects:

At the Preston Uranium Project, strategically located proximal to Fission Uranium Corp.'s shallow, high-grade Triple R deposit as well as NexGen Energy Ltd.'s Arrow discovery, Skyharbour and the Western Athabasca Syndicate are planning a summer exploration and diamond drill program to commence in August. The results from the most recently-completed geophysical surveys, combined with exploration results from previous field work, are being used to prioritize and refine targets for a planned drill program at Preston. Details of this summer exploration and drill program are forthcoming with Skyharbour as the operator of the project.

The Western Athabasca Syndicate has carried out one of the largest regional exploration programs in the underexplored SW region of the Athabasca Basin. A total of approx. $4.2 million in expenditures on the Preston Uranium Project has been incurred including ground gravity, airborne and ground EM and magnetics, radon, soil, silt, biogeochem, lake sediment, and geological mapping surveys, as well as boulder prospecting and a nine hole exploratory diamond drill program. As a result of this multi-million dollar exploration program, fifteen high-priority drill target areas associated with eight prospective exploration corridors have been successfully delineated using a methodical, multi-phased exploration technique. In addition, the Syndicate holds an extensive, proprietary geological database for the project area as a byproduct of its substantial exploration work over the past twenty months.

Preston Uranium Property Map and Regional Exploration Corridors:

http://skyharbourltd.com/_resources/SYH_Regional_Corridors.jpg

Skyharbour has also commenced a follow-up field program at its 100% owned, 79,003 hectare Falcon Point Uranium and Thorium Property located 55 kilometres east of the Key Lake Mill. This program will consist of detailed prospecting and vegetation/soil sampling at the Hook Lake target area where historical exploration returned high grade uranium grab samples with up to 48% U3O8 from a massive pitchblende vein exposed at surface. Previous operators have been unable to definitively explain and locate the source of the high grade uranium and thorium mineralization at the Hook Lake target. News will be forthcoming on this program as it is completed over the next few weeks.

Falcon Point Uranium/Thorium Project Geophysics Map: http://skyharbourltd.com/_resources/SYH%20Falcon%20Point%20Zones%20Map.jpg

Assessment Credit Relief Granted for All Skyharbour's Projects in the Athabasca Basin:

The government of Saskatchewan has granted regulatory relief to Skyharbour with respect to all four of its drill-ready uranium projects in Northern Saskatchewan. The regulatory decisions follow government reviews and legal submissions made by Skyharbour with respect to the forest fire situation in Saskatchewan.

As a result of the regulatory decision, the Company advises that work requirements for the current assessment period at the properties have been satisfied by way of regulatory relief. The relief has been granted to the Company's Falcon Point, Preston, Mann Lake and Yurchison Lake Projects in the Athabasca Basin which cover a combined total of 222,631 hectares. This equates to $3,470,605 in assessment work credits that Skyharbour has been granted to apply towards the mineral claims it has an ownership stake in.

Qualified Statement:

The technical information in this news release has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43-101 and reviewed and approved by Richard Kusmirski, P.Geo., M.Sc., Skyharbour's Head Technical Advisor and a Director, as well as a Qualified Person.

About Skyharbour Resources Ltd.:

Skyharbour holds interest in an extensive portfolio of uranium and thorium exploration projects in Canada's Athabasca Basin and is well positioned to benefit from improving uranium market fundamentals with four drill-ready projects. The Company is the operator of the Western Athabasca Syndicate which controls a large, geologically prospective land package consisting of five properties in the Athabasca Basin of Saskatchewan. Skyharbour also owns a 100% interest in the Falcon Point (formerly Way Lake) Uranium Project on the east side of the Basin which hosts a NI 43-101 inferred resource totaling 7.0 million pounds of U3O8 at 0.03% and 5.3 million pounds of ThO2 at 0.023%. The Company owns a 60% interest in the Mann Lake Uranium project on the east side of the Basin strategically located adjacent to the Mann Lake Joint Venture operated by Cameco with partners Denison Mines and AREVA where high-grade, basement-hosted uranium mineralization was recently discovered. Skyharbour's goal is to maximize shareholder value through new mineral discoveries, committed long-term partnerships, and the advancement of exploration projects in geopolitically favourable jurisdictions.

To find out more about Skyharbour Resources Ltd. (TSX-V:SYH) visit the Company's website at www.skyharbourltd.com.

SKYHARBOUR RESOURCES LTD.

"Jordan Trimble"                                                 
Jordan Trimble
President and CEO

For further information contact myself or:
Don Myers
Director
Skyharbour Resources Ltd.
Telephone: 604-687-3376
Toll Free: 800-567-8181
Facsimile: 604-687-3119
Email: info@skyharbourltd.com

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THE CONTENT OF THIS NEWS RELEASE.

This release includes certain statements that may be deemed to be "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that management of the Company expects, are forward-looking statements. Although management believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual results or developments may differ materially from those in the forward-looking statements. The Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change. Factors that could cause actual results to differ materially from those in forward-looking statements, include market prices, exploration and development successes, continued availability of capital and financing, and general economic, market or business conditions. Please see the public filings of the Company at www.sedar.com for further information.

CONTACT: Telephone: (604) 687-3376
         Facsimile: (604) 687-3119
         Email: info@skyharbourltd.com

Skyharbour Resources Ltd logo

NEXT ARTICLE

More From BioPortfolio on "Skyharbour Update on Summer Drill and Field Programs, Assessment Credit Relief Granted for All Projects in the Athabasca Basin"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.